Advertisement

Topics

"BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial" Drugs and Medication Database

17:55 EST 19th February 2019 | BioPortfolio

Here are the most relevant "BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial" Drugs and Medications that we have found in our database.

More Information about "BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial" on BioPortfolio

We have published hundreds of BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial news stories on BioPortfolio along with dozens of BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial Clinical Trials and PubMed Articles about BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial Companies in our database. You can also find out about relevant BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial Drugs and Medications on this site too.

Showing "BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial" Drugs and Medications, all 20

Relevant

Alferon [hemispherx biopharma, inc]

NA

Probably Relevant

Yupelri [the ritedose corporation]

Yupelri (Revefenacin) Inhalation Solution 175 mcg/3 mL

Possibly Relevant

Keveyis [strongbridge us inc.]

These highlights do not include all the information needed to use KEVEYIS safely and effectively. See full prescribing information for KEVEYIS. KEVEYIS (dichlorphenamide) tablets, for oral use Initial U.S. Approval: 1958

Carbon dioxide oxygen mixture [air liquide healthcare america corporation]

CARBON DIOXIDE OXYGEN MIXTURE COMPRESSED

Compressed gas, oxidizing, n.o.s. [air liquide healthcare america corporation]

NA

Oral-b neutra-foam mint [oral-b laboratories]

Package. Label Principal Display Panel

Macrilen [strongbridge u.s. inc]

These highlights do not include all the information needed to use MACRILEN safely and effectively. See full prescribing information for MACRILEN.MACRILEN (macimorelin) for oral solution Initial U.S. Approval: 2017

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Iclusig [millennium pharmaceuticals, inc.]

These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG(ponatinib) tablets, for oral use Initial U.S. Approval: 2012

Ez-ox plus [air liquide america l.p.]

NA

Mektovi [array biopharma inc.]

These highlights do not include all the information needed to use MEKTOVI safely and effectively. See full prescribing information for MEKTOVI. MEKTOVI (binimetinib) tablets, for oral use Initial U.S. Approval: 2018

Tamiflu [physicians total care, inc.]

These highlights do not include all the information needed to use TAMIFLU safely and effectively. See full prescribing information for TAMIFLU. TAMIFLU (oseltamivir phosphate) capsules TAMIFLU (oseltamivir phosphate) for oral suspension Initial U.S. Appro

Sodium fluoride f 18 [global isotopes, llc d/b/a zevacor molecular]

These highlights do not include all the information needed to use Sodium Fluoride F18 Injection safely and effectively. See full prescribing information for Sodium Fluoride F18 Injection. Sodium Fluoride F18 Injection, USP for intravenous use Initial U.S.

Tamiflu [rebel distributors corp]

These highlights do not include all the information needed to use TAMIFLU safely and effectively. See full prescribing information for TAMIFLU. TAMIFLU (oseltamivir phosphate) capsules TAMIFLU (oseltamivir phosphate) for oral suspension Initial U.S. Appro

Vibativ [theravance biopharma r&d, inc.]

These highlights do not include all the information needed to use VIBATIV (telavancin) safely and effectively. See full prescribing information for VIBATIV. VIBATIV (telavancin) for injection, for intravenous useInitial U.S. Approval: 2009 To reduce the d

Sprycel [e.r. squibb & sons, l.l.c.]

These highlights do not include all the information needed to use SPRYCEL safely and effectively. See full prescribing information for SPRYCEL. SPRYCEL (dasatinib) tablets, for oral useInitial U.S. Approval: 2006

Sodium thiosulfate [hope pharmaceuticals]

These highlights do not include all the information needed to use the Sodium Thiosulfate Injection safely and effectively. See full prescribing information for Sodium Thiosulfate Injection. Sodium Thiosulfate Injection, USPInitial U.S. Approval: 1992

Sodium fluoride f 18 [spectron mrc, llc]

Sodium Fluoride F 18 Injection HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Sodium Fluoride F 18 Injection safely and effectively. See full prescribing information for Sodium Fluoride F 18 Injecti



Advertisement
Quick Search
Advertisement
Advertisement